Skip to main content
Top

17-09-2018 | Large-vessel vasculitis | Review | Article

Diagnosis and differential diagnosis of large-vessel vasculitides

Journal: Rheumatology International

Authors: Gokhan Keser, Kenan Aksu

Publisher: Springer Berlin Heidelberg

Abstract

There are no universally accepted diagnostic criteria for large-vessel vasculitides (LVV), including giant cell arteritis (GCA) and Takayasu arteritis (TAK). Currently, available classification criteria cannot be used for the diagnosis of GCA and TAK. Early diagnosis of these two diseases is quite challenging in clinical practice and may be accomplished only by combining the patient symptoms, physical examination findings, blood test results, imaging findings, and biopsy results, if available. Awareness of red flags which lead the clinician to investigate TAK in a young patient with persistent systemic inflammation is helpful for the early diagnosis. It should be noted that clinical presentation may be highly variable in a subgroup of GCA patients with predominant large-vessel involvement (LVI) and without prominent cranial symptoms. Imaging modalities are especially helpful for the diagnosis of this subgroup. Differential diagnosis between older patients with TAK and this subgroup of GCA patients presenting with LVI may be difficult. Various pathologies may mimic LVV either by causing systemic inflammation and constitutional symptoms, or by causing lumen narrowing with or without aneurysm formation in the aorta and its branches. Differential diagnosis of aortitis is crucial. Infectious aortitis including mycotic aneurysms due to septicemia or endocarditis, as well as causes such as syphilis and mycobacterial infections should always be excluded. On the other hand, the presence of non-infectious aortitis is not unique for TAK and GCA. It should be noted that aortitis, other large-vessel involvement or both, may occasionally be seen in various other autoimmune pathologies including ANCA-positive vasculitides, Behçet’s disease, ankylosing spondylitis, sarcoidosis, and Sjögren’s syndrome. Besides, aortitis may be idiopathic and isolated. Atherosclerosis should always be considered in the differential diagnosis of LVV. Other pathologies which may mimic LVV include, but not limited to, congenital causes of aortic coarctation and middle aortic syndrome, immunoglobulin G4-related disease, and hereditary disorders of connective tissue such as Marfan syndrome and Ehler–Danlos syndrome.
Literature
1.
Jennette JC, Falk R, Bacon P, Basu N, Cid M, Ferrario F, Flores-Suarez L, Gross W, Guillevin L, Hagen E (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11CrossRef
2.
Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, Brunner HI, Ogawa R, Felson D, Ogdie A (2015) Distinctions between diagnostic and classification criteria? Arthritis Care Res 67(7):891–897CrossRef
3.
de Souza AWS, de Carvalho JF (2014) Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun 48:79–83CrossRefPubMed
4.
Ishikawa K (1988) Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu’s arteriopathy. J Am Coll Cardiol 12(4):964–972CrossRefPubMed
5.
Sharma B, Jain S, Suri S, Numano F (1996) Diagnostic criteria for Takayasu arteritis. Int J Cardiol 54:S127–S133CrossRef
6.
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie J, Lightfoot RW (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134CrossRefPubMed
7.
Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie J (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum Off J Am Coll Rheumatol 33(8):1122–1128CrossRef
8.
Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, Brouwer E, Cimmino MA, Clark E, Dasgupta B (2018) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77(5):636–643CrossRefPubMed
9.
Sait MR, Lepore M, Kwasnicki R, Allington J, Balasubramanian R, Somasundaram SK, Vashisht R, Barkeji M (2017) The 2016 revised ACR criteria for diagnosis of giant cell arteritis—our case series: can this avoid unnecessary temporal artery biopsies? Int J Surg 9:19–23
10.
Craven A, Robson J, Ponte C, Grayson PC, Suppiah R, Judge A, Watts R, Merkel PA, Luqmani RA (2013) ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). Clin Exp Nephrol 17(5):619–621CrossRefPubMed
11.
Kobayashi S, Fujimoto S (2013) Epidemiology of vasculitides: differences between Japan, Europe and North America. Clin Exp Nephrol 17(5):611–614CrossRefPubMedPubMedCentral
12.
Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929CrossRefPubMed
13.
Salvarani C, Cantini F, Boiardi L, Hunder G (2003) Laboratory investigations useful in giant cell arteritis and Takayasu’s arteritis. Clin Exp Rheumatol 21(6:SUPP/32):S23–S28PubMed
14.
Kobayashi Y, Numano F (2002) 3. Takayasu arteritis. Intern Med 41(1):44–46CrossRefPubMed
15.
Salvarani C, Hunder GG (2001) Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Care Res 45(2):140–145CrossRef
16.
Eklund KK, Niemi K, Kovanen P (2012) Immune functions of serum amyloid A. Crit Rev Immunol 32(4):335–348CrossRefPubMed
17.
Keser G, Aksu K, Direskeneli H (2017) Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited. Rheumatology 57(5):784–790CrossRef
18.
Jaillon S, Bonavita E, Gentile S, Rubino M, Laface I, Garlanda C, Mantovani A (2014) The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases. Int Arch Allergy Immunol 165(3):165–178CrossRefPubMed
19.
Alibaz-Oner F, Aksu K, Yentur S, Keser G, Saruhan-Direskeneli G, Direskeneli H (2016) Plasma pentraxin-3 levels in patients with Takayasu’s arteritis during routine follow-up. Clin Exp Rheumatol 34(3 Suppl 97):S73–S76PubMed
20.
Tombetti E, Di Chio MC, Sartorelli S, Papa M, Salerno A, Bottazzi B, Bozzolo EP, Greco M, Rovere-Querini P, Baldissera E (2014) Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Arthritis Res Ther 16(6):479CrossRefPubMedPubMedCentral
21.
Dagna L, Salvo F, Tiraboschi M, Bozzolo EP, Franchini S, Doglioni C, Manfredi AA, Baldissera E, Sabbadini MG (2011) Pentraxin-3 as a marker of disease activity in Takayasu arteritis. Ann Intern Med 155(7):425–433CrossRefPubMed
22.
Barra L, Kanji T, Malette J, Pagnoux C, Vasc C (2018) Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: a systematic review and meta-analysis. Autoimmun Rev 17(2):175–187CrossRefPubMed
23.
Mavrogeni S, Dimitroulas T, Chatziioannou SN, Kitas G (2013) The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum 42(4):401–412CrossRefPubMed
24.
Muratore F, Pipitone N, Salvarani C, Schmidt WA (2016) Imaging of vasculitis: state of the art. Best Pract Res Clin Rheumatol 30(4):688–706CrossRefPubMed
25.
Schmidt WA (2013) Imaging in vasculitis. Best Pract Res Clin Rheumatol 27(1):107–118CrossRefPubMed
26.
Hartlage GR, Palios J, Barron BJ, Stillman AE, Bossone E, Clements SD, Lerakis S (2014) Multimodality imaging of aortitis. JACC Cardiovasc Imaging 7(6):605–619CrossRefPubMed
27.
Papa M, De Cobelli F, Baldissera E, Dagna L, Schiani E, Sabbadini M, Del Maschio A (2012) Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. Am J Roentgenol 198(3):W279–W284CrossRef
28.
Eshet Y, Pauzner R, Goitein O, Langevitz P, Eshed I, Hoffmann C, Konen E (2011) The limited role of MRI in long-term follow-up of patients with Takayasu’s arteritis. Autoimmun Rev 11(2):132–136CrossRefPubMed
29.
Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS (2002) Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum Off J Am Coll Rheumatol 46(6):1634–1642CrossRef
30.
Garg SK, Mohan S, Kumar S (2011) Diagnostic value of 3D contrast-enhanced magnetic resonance angiography in Takayasu’s arteritis—a comparative study with digital subtraction angiography. Eur Radiol 21(8):1658–1666CrossRefPubMed
31.
Chung JW, Kim H-C, Choi YH, Kim SJ, Lee W, Park JH (2007) Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 45(5):906–914CrossRefPubMed
32.
Yoshida S, Akiba H, Tamakawa M, Yama N, Takeda M, Hareyama M, Nakata T, Shimamoto K (2001) The spectrum of findings in supra-aortic Takayasu’s arteritis as seen on spiral CT angiography and digital subtraction angiography. Cardiovasc Intervent Radiol 24(2):117–121CrossRefPubMed
33.
Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, Dasgupta B, Diamantopoulos AP, Forrester-Barker W, Hamilton W (2016) The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 20(90):1–238CrossRefPubMedPubMedCentral
34.
Schäfer VS, Juche A, Ramiro S, Krause A, Schmidt WA (2017) Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis. Rheumatology 56(9):1479–1483CrossRefPubMed
35.
Germanò G, Muratore F, Cimino L, Lo Gullo A, Possemato N, Macchioni P, Cavazza A, Pipitone N, Boiardi L, Salvarani C (2014) Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatology 54(3):400–404CrossRefPubMed
36.
Karapolat I, Kalfa M, Keser G, Yalçin M, Inal V, Kumanlioğlu K, Pirildar T, Aksu K (2013) Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu’s arteritis. Clin Exp Rheumatol 31(1 Suppl 75):S15–S21PubMed
37.
Santhosh S, Mittal BR, Gayana S, Bhattacharya A, Sharma A, Jain S (2014) F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics. J Nucl Cardiol 21(5):993–1000CrossRefPubMed
38.
Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki J-I, Hirao K, Isobe M (2012) Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 5(4):422–429CrossRefPubMed
39.
Cheng Y, Lv N, Wang Z, Chen B, Dang A (2013) 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol 31(1 Suppl 75):S22–S27PubMed
40.
Incerti E, Tombetti E, Fallanca F, Baldissera EM, Alongi P, Tombolini E, Sartorelli S, Sabbadini MG, Papa M, De Cobelli F (2017) 18 F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging 44(7):1109–1118CrossRefPubMed
41.
Einspieler I, Thürmel K, Pyka T, Eiber M, Wolfram S, Moog P, Reeps C, Essler M (2015) Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging 42(7):1012–1024CrossRefPubMed
42.
Vanoli M, Daina E, Salvarani C, Sabbadini M, Rossi C, Bacchiani G, Schieppati A, Baldissera E, Bertolini G (2005) Takayasu’s arteritis: a study of 104 Italian patients. Arthritis Care Res 53(1):100–107CrossRef
43.
Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer H, Seyahi E, Akar S, Onen F (2009) Takayasu’s arteritis in Turkey—clinical and angiographic features of 248 patients. Clin Exp Rheumatol 27(1):S59PubMed
44.
Park MC, Lee SW, Park YB, Chung N, Lee SK (2005) Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 34(4):284–292CrossRefPubMed
45.
Grayson PC, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Monach PA, Seo P (2013) New features of disease after diagnosis in 6 forms of systemic vasculitis. J Rheumatol 40(11):1905–1912CrossRefPubMedPubMedCentral
46.
Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y (2010) EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69(5):798–806CrossRefPubMed
47.
Sheikhzadeh A, Ghabussi P, Razi M (1982) Occlusive thromboaortopathy (Takayasu’s disease): clinical findings and angiographic classification. Herz 7(5):325–330PubMed
48.
Nasu T (1982) Takayasu’s truncoarteritis. Pulseless disease or aortitis syndrome. Acta Pathol Jpn 32:117–131PubMed
49.
Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54:S155–S163CrossRefPubMed
50.
Nazareth R, Mason J (2010) Takayasu arteritis: severe consequences of delayed diagnosis. QJM 104(9):797–800
51.
Chugh KS, Sakhuja V (1992) Takayasu’s arteritis as a cause of renovascular hypertension in Asian countries. Am J Nephrol 12(1–2):1–8CrossRefPubMed
52.
Weyand CM, Goronzy JJ (2014) Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371(1):50–57CrossRefPubMedPubMedCentral
53.
Weyand CM, Goronzy JJ (2013) Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol 9(12):731–740CrossRefPubMedPubMedCentral
54.
Brack A, Martinez-Taboada V, Stanson A, Goronzy J, Weyand C (1999) Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum Off J Am Coll Rheumatol 42(2):311–317CrossRef
55.
de Boysson H, Daumas A, Vautier M, Parienti J-J, Liozon E, Lambert M, Samson M, Ebba M, Dumont A, Sultan A (2018) Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients. Autoimmun Rev 17(4):391–398CrossRefPubMed
56.
Muratore F, Kermani TA, Crowson CS, Koster MJ, Matteson EL, Salvarani C, Warrington KJ (2018) Large vessel dilatation in giant cell arteritis: a different subset of disease? Arthritis Care Res. https://​doi.​org/​10.​1002/​acr.​23498 CrossRef
57.
Taylor-Gjevre R, Vo M, Shukla D, Resch L (2005) Temporal artery biopsy for giant cell arteritis. J Rheumatol 32(7):1279–1282PubMed
58.
Breuer GS, Nesher G, Nesher R (2009) Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol 36(4):794–796CrossRefPubMed
59.
Niederkohr RD, Levin LA (2007) A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Investig Ophthalmol Vis Sci 48(2):675–680CrossRef
60.
Maksimowicz-McKinnon K, Clark TM, Hoffman GS (2009) Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine (Baltimore) 88(4):221–226CrossRef
61.
O’Neill L, Ponte C, Sznajd J, Rodrigues AP, Seeliger B, Luqmani RA (2015) Giant cell arteritis and Takayasu arteritis: are they a different spectrum of the same disease? IJR 10(Suppl 1):S11–S21
62.
Furuta S, Cousins C, Chaudhry A, Jayne D (2015) Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? J Rheumatol 42(2):300–308CrossRefPubMed
63.
Kermani TA (2018) Takayasu arteritis and giant cell arteritis: are they a spectrum of the same disease? Int J Rheum Dis. https://​doi.​org/​10.​1111/​1756-185X.​13288 CrossRefPubMed
64.
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J (2017) Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377(4):317–328CrossRefPubMed
65.
Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N (2018) Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis 77(3):348–354CrossRefPubMed
66.
Carmona FD, Coit P, Saruhan-Direskeneli G, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Vaglio A, Direskeneli H, Merkel PA (2017) Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy. Sci Rep 7:43953CrossRefPubMedPubMedCentral
67.
Carmona FD, Martín J, González-Gay MA (2015) Genetics of vasculitis. Curr Opin Rheumatol 27(1):10–17CrossRefPubMed
68.
Stone JR, Bruneval P, Angelini A, Bartoloni G, Basso C, Batoroeva L, Buja LM, Butany J, d’Amati G, Fallon JT (2015) Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol 24(5):267–278CrossRefPubMed
69.
Kermani TA, Crowson CS, Muratore F, Schmidt J, Matteson EL, Warrington KJ (2015) Extra-cranial giant cell arteritis and Takayasu arteritis: how similar are they? Semin Arthritis Rheum 44(6):724–728CrossRefPubMed
70.
Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, Khalidi NA, Langford CA, Monach PA, Seo P (2012) Distribution of arterial lesions in Takayasu’s arteritis and giant cell arteritis. Ann Rheum Dis 71(8):1329–1334CrossRefPubMed
71.
Saadoun D, Garrido M, Comarmond C, Desbois A, Domont F, Savey L, Terrier B, Geri G, Rosenzwajg M, Klatzmann D (2015) Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol 67(5):1353–1360CrossRefPubMed
72.
Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM (2010) Th17 and Th1 T-cell responses in giant cell arteritis. Circulation 121(7):906–915CrossRefPubMedPubMedCentral
73.
Weyand CM, Younge BR, Goronzy JJ (2011) IFN-γ and IL-17-the two faces of T cell pathology in giant cell arteritis. Curr Opin Rheumatol 23(1):43–49CrossRefPubMedPubMedCentral
74.
Schmidt J, Kermani TA, Bacani AK, Crowson CS, Matteson EL, Warrington KJ (2012) Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup. Arthritis Care Res 64(7):1079–1083
75.
Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P (2004) Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum Off J Am Coll Rheumatol 50(7):2296–2304CrossRef
76.
Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 146(9):621–630CrossRefPubMed
77.
Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL (2017) A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis. Arthritis Rheum 69(4):837–845CrossRef
78.
Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL (2017) A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis. Arthritis Rheumatol 69(4):846–853CrossRefPubMedPubMedCentral
79.
Thomas K, Vassilopoulos D (2017) Infections and vasculitis. Curr Opin Rheumatol 29(1):17–23CrossRefPubMed
80.
Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, ParIès J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Care Res 57(8):1473–1480CrossRef
81.
Gornik HL, Creager MA (2008) Aortitis. Circulation 117(23):3039–3051CrossRefPubMedPubMedCentral
82.
Scheel A, Meller J, Vosshenrich R, Kohlhoff E, Siefker U, Müller G, Strutz F (2004) Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 63(11):1507–1510CrossRefPubMedPubMedCentral
83.
Tavora F, Burke A (2006) Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu’s and giant cell aortitis. Pathology (Phila) 38(4):302–308
84.
Lopes R, Almeida J, Dias P, Pinho P, Maciel M (2009) Infectious thoracic aortitis: a literature review. Clin Cardiol 32(9):488–490CrossRefPubMedPubMedCentral
85.
Foote EA, Postier RG, Greenfield RA, Bronze MS (2005) Infectious aortitis. Curr Treat Options Cardiovasc Med 7(2):89–97CrossRefPubMed
86.
Khasnis A (2009) Mimics of primary systemic vasculitides. Int J Clin Rheumatol 4(5):597–609CrossRef
87.
Malouf JF, Chandrasekaran K, Orszulak TA (2003) Mycotic aneurysms of the thoracic aorta: a diagnostic challenge. Am J Med 115(6):489–496CrossRefPubMed
88.
Chetty R (2001) Vasculitides associated with HIV infection. J Clin Pathol 54(4):275–278CrossRefPubMedPubMedCentral
89.
Lee W-K, Mossop PJ, Little AF, Fitt GJ, Vrazas JI, Hoang JK, Hennessy OF (2008) Infected (mycotic) aneurysms: spectrum of imaging appearances and management. Radiographics 28(7):1853–1868CrossRefPubMed
90.
Sokalski D, Spring TC, Roberts W (2013) Large artery inflammation in systemic lupus erythematosus. Lupus 22(9):953–956CrossRefPubMed
91.
Loricera J, Blanco R, Hernández J, Carril J, Martínez-Rodríguez I, Canga A, Peiró E, Alonso-Gutiérrez J, Calvo-Río V, Ortiz-Sanjuán F (2015) Non-infectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review. Clin Exp Rheumatol 33(2 Suppl 89):S19
92.
Kaneko S, Yamashita H, Sugimori Y, Takahashi Y, Kaneko H, Kano T, Mimori A (2014) Rheumatoid arthritis-associated aortitis: a case report and literature review. Springerplus 3:509CrossRefPubMedPubMedCentral
93.
Amos LA, Roberts MA, Blair S, McMahon LP (2012) cANCA-associated aortitis. Clin Kidney J 5(1):47–49CrossRefPubMedPubMedCentral
94.
Chirinos JA, Tamariz LJ, Lopes G, Del Carpio F, Zhang X, Milikowski C, Lichtstein DM (2004) Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clin Rheumatol 23(2):152–159CrossRefPubMed
95.
Palazzi C, Salvarani C, D’Angelo S, Olivieri I (2011) Aortitis and periaortitis in ankylosing spondylitis. Jt Bone Spine 78(5):451–455CrossRef
96.
Tufan A, Tezcan ME, Kaya A, Mercan R, Oner Y, Ozturk MA (2012) Aortitis in a patient with psoriatic arthritis. Mod Rheumatol 22(5):774–777CrossRefPubMed
97.
Chapelon-Abric C, Saadoun D, Marie I, Comarmond C, Desbois AC, Domont F, Savey L, Cacoub P (2018) Sarcoidosis with Takayasu arteritis: a model of overlapping granulomatosis. A report of seven cases and literature review. Int J Rheum Dis 21(3):740–745CrossRefPubMed
98.
Ho AC, Roat MI, Venbrux A, Hellmann DB (1999) Cogan’s syndrome with refractory abdominal aortitis and mesenteric vasculitis. J Rheumatol 26(6):1404–1407PubMed
99.
Selim AA, Fulford L, Mohiaddin R, Sheppard M (2001) Active aortitis in relapsing polychondritis. J Clin Pathol 54(11):890–892CrossRefPubMedPubMedCentral
100.
Gaduputi V, Tariq H, Kanneganti K (2014) Abdominal aortitis associated with Crohn disease. Can J Gastroenterol Hepatol 28(2):69–70CrossRefPubMedPubMedCentral
101.
DomÈnech E, Garcia-Planella E, OlazÁbal A, SÁnchez-Delgado J, Zabana Y, Bernal I, Mañosa M, Olivé A, Gassull MA (2005) Abdominal aortitis associated with Crohn’s disease. Dig Dis Sci 50(6):1122–1123CrossRefPubMed
102.
Tsui K-L, Lee K-W, Chan W-K, Chan HK-Y, Hon SF-K, Leung T-C, Lee K-L, Tsoi T-H, Li S-K (2004) Behçet’s aortitis and aortic regurgitation: a report of two cases. J Am Soc Echocardiogr 17(1):83–86CrossRefPubMed
103.
Stone JH, Khosroshahi A, Deshpande V, Stone JR (2010) IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res 62(3):316–322CrossRef
104.
Pipitone N, Salvarani C (2011) Idiopathic aortitis: an underrecognized vasculitis. Arthritis Res Ther 13(4):119CrossRefPubMedPubMedCentral
105.
Schmidt J, Sunesen K, Kornum JB, Duhaut P, Thomsen RW (2011) Predictors for pathologically confirmed aortitis after resection of the ascending aorta: a 12-year Danish nationwide population-based cross-sectional study. Arthritis Res Ther 13(3):R87CrossRefPubMedPubMedCentral
106.
Liang KP, Chowdhary VR, Michet CJ, Miller DV, Sundt TM, Connolly HM, Crowson CS, Matteson EL, Warrington KJ (2009) Noninfectious ascending aortitis: a case series of 64 patients. J Rheumatol 36(10):2290–2297CrossRefPubMed
107.
Talarico R, Boiardi L, Pipitone N, d’Ascanio A, Stagnaro C, Ferrari C, Elefante E, Salvarani C, Bombardieri S (2014) Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin? Clin Exp Rheumatol 32(3 Suppl 82):S55–S58PubMed
108.
Seyahi E, Ugurlu S, Cumali R, Balci H, Seyahi N, Yurdakul S, Yazici H (2006) Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 65(9):1202–1207CrossRefPubMedPubMedCentral
109.
Seyahi E, Ucgul A, Olgun DC, Ugurlu S, Akman C, Tutar O, Yurdakul S, Yazici H (2013) Aortic and coronary calcifications in Takayasu arteritis. Semin Arthritis Rheum 43(1):96–104CrossRefPubMed
110.
Wasserman BA (2010) Advanced contrast-enhanced MRI for looking beyond the lumen to predict stroke: building a risk profile for carotid plaque. Stroke 41(10 suppl 1):S12–S16CrossRefPubMed
111.
Hoffman GS (2003) Large-vessel vasculitis: unresolved issues. Arthritis Rheum Off J Am Coll Rheumatol 48(9):2406–2414CrossRef
112.
Pipitone N, Versari A, Salvarani C (2008) Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology 47(4):403–408CrossRefPubMed
113.
Blockmans D (2003) The use of (18F) fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 21(6:SUPP/32):S15–S22PubMed
114.
Salonen JT, Salonen R (1993) Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 87(3 Suppl):II56–II65PubMed
115.
Maeda H, Handa N, Matsumoto M, Hougaku H, Ogawa S, Oku N, Itoh T, Moriwaki H, Yoneda S, Kimura K (1991) Carotid lesions detected by B-mode ultrasonography in Takayasu’s arteritis: “macaroni sign” as an indicator of the disease. Ultrasound Med Biol 17(7):695–701CrossRefPubMed
116.
Sigl M, Hsu E, Scheffel H, Haneder S, Rumenapf G, Amendt K (2014) Lower extremity vasculitis in giant cell arteritis: important differential diagnosis in patients with lower limb claudication. Vasa 43(5):326–336CrossRefPubMed
117.
Bao N, Cao H-R, Zhang W-H, Zhang Y (2013) Arteritis mimicking aortic coarctation and review of the literature. JMC 4(6):376–379
118.
Janzen J, Vuong PN, Rothenberger-Janzen K (1999) Takayasu’s arteritis and fibromuscular dysplasia as causes of acquired atypical coarctation of the aorta: retrospective analysis of seven cases. Heart Vessels 14(6):277–282CrossRefPubMed
119.
Delis KT, Gloviczki P (2005) Middle aortic syndrome: from presentation to contemporary open surgical and endovascular treatment. Perspect Vasc Surg Endovasc Ther 17(3):187–203CrossRefPubMed
120.
Zucker EJ (2018) Syndromes with aortic involvement: pictorial review. Cardiovasc Diagn Ther 8(Suppl 1):S71–S81CrossRefPubMedPubMedCentral
121.
Milewicz DM, Dietz HC, Miller DC (2005) Treatment of aortic disease in patients with Marfan syndrome. Circulation 111(11):e150–e157CrossRefPubMed
122.
Pepin M, Schwarze U, Superti-Furga A, Byers PH (2000) Clinical and genetic features of Ehlers–Danlos syndrome type IV, the vascular type. N Engl J Med 342(10):673–680CrossRefPubMed
123.
Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S (2006) Aneurysm syndromes caused by mutations in the TGF-β receptor. N Engl J Med 355(8):788–798CrossRefPubMed
124.
Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL (2009) Neurofibromatosis type 1 revisited. Pediatrics 123(1):124–133CrossRefPubMed
125.
Borofsky S, Levy LM (2013) Neurofibromatosis: types 1 and 2. Am J Neuroradiol 34(12):2250–2251CrossRefPubMedPubMedCentral
126.
Olin JW, Sealove BA (2011) Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg 53(3):826–836CrossRefPubMed
127.
Churchill CH, Abril A, Krishna M, Callman ML, Ginsburg WW (2003) Jaw claudication in primary amyloidosis: unusual presentation of a rare disease. J Rheumatol 30(10):2283–2286PubMed
128.
Salvarani C, Gabriel SE, Gertz MA, Bjornsson J, Li CY, Hunder GG (1994) Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum Off J Am Coll Rheumatol 37(11):1621–1626CrossRef
129.
Estrada-Veras JI, O’Brien KJ, Boyd LC, Dave RH, Durham BH, Xi L, Malayeri AA, Chen MY, Gardner PJ, Enriquez JRA (2017) The clinical spectrum of Erdheim–Chester disease: an observational cohort study. Blood Adv 1(6):357–366CrossRefPubMedPubMedCentral
130.
Baker-LePain JC, Stone DH, Mattis AN, Nakamura MC, Fye KH (2010) Clinical diagnosis of segmental arterial mediolysis: differentiation from vasculitis and other mimics. Arthritis Care Res 62(11):1655–1660CrossRef
131.
Mertz LE, Conn DL (1992) Vasculitis associated with malignancy. Curr Opin Rheumatol 4(1):39–46PubMed